Shopping Cart
- Remove All
Your shopping cart is currently empty
Arimoclomol (BRX-220 free base), a co-inducer of heat shock proteins (HSP), is utilized in studies on the treatment of amyotrophic lateral sclerosis (ALS).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $92 | In Stock | |
| 5 mg | $226 | In Stock | |
| 10 mg | $347 | In Stock | |
| 25 mg | $577 | In Stock | |
| 50 mg | $823 | In Stock | |
| 100 mg | $1,090 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $235 | In Stock |
| Description | Arimoclomol (BRX-220 free base), a co-inducer of heat shock proteins (HSP), is utilized in studies on the treatment of amyotrophic lateral sclerosis (ALS). |
| In vivo | In male Wistar rats, Arimoclomol (20 mg/kg; gavage) protects cholecystokinin-octapeptide (CCK)-induced acute pancreatitis. The pancreatic levels of HSP60 and HSP72 are significantly increased[2]. |
| Synonyms | BRX-220 free base |
| Molecular Weight | 313.78 |
| Formula | C14H20ClN3O3 |
| Cas No. | 289893-25-0 |
| Smiles | C(=NOC[C@@H](CN1CCCCC1)O)(Cl)C2=CN(=O)=CC=C2 |
| Relative Density. | 1.32 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 65 mg/mL (207.15 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.